ارسل ملاحظاتك

ارسل ملاحظاتك لنا







Impact of Marketing Costs and the Research and Development on the Profitability of Egypt's Pharmaceutical Companies

المصدر: المجلة العلمية للدراسات المحاسبية
الناشر: جامعة قناة السويس - كلية التجارة
المؤلف الرئيسي: Abdo, Bassant Badr Eldin (Author)
مؤلفين آخرين: Abouzeid, Walid Aboubakr (Co-Author)
المجلد/العدد: مج1, ع2
محكمة: نعم
الدولة: مصر
التاريخ الميلادي: 2019
الصفحات: 40 - 67
ISSN: 2636-3739
رقم MD: 1098795
نوع المحتوى: بحوث ومقالات
اللغة: الإنجليزية
قواعد المعلومات: EcoLink
مواضيع:
كلمات المؤلف المفتاحية:
Marketing Costs | Research and Development | Profitability | Pharmaceutical Companies
رابط المحتوى:
صورة الغلاف QR قانون

عدد مرات التحميل

12

حفظ في:
LEADER 02266nam a22002297a 4500
001 1839936
041 |a eng 
044 |b مصر 
100 |9 591414  |a Abdo, Bassant Badr Eldin  |e Author 
245 |a Impact of Marketing Costs and the Research and Development on the Profitability of Egypt's Pharmaceutical Companies 
260 |b جامعة قناة السويس - كلية التجارة  |c 2019 
300 |a 40 - 67 
336 |a بحوث ومقالات  |b Article 
520 |b The main objective of this study is to examine the impact of marketing and R&D expenditures on the competitiveness of Egypt's pharmaceutical companies. In this report, Egypt Stock Exchange admitted pharmaceutical companies. Data estimator random-effect panel was used for this purpose. The results indicate that variables such as the size of a business, the capital-to-total ratio of assets and the debt-to-asset ratio affect profitability. Nonetheless, on competitiveness, business life, advertisement costs and spending in R&D are unsuccessful. Legal concerns such as the absence of patent law and the framework for pricing are reasons for the poor partnership between R&D and marketing costs and its effect on income, The results indicate that variables such as the size of a business, the capital--ratio of assets and the debt--ratio affect profitability. Nonetheless, on competitiveness, business life, advertisement costs and spending in R&D are unsuccessful. Regulatory problems including the lack of & absence of patent law and pricing controls are reasons for the poor partnership between R&D and marketing costs and its impact on the Egyptian pharmaceutical industry's profitability 
653 |a المحاسبة المالية  |a إدارة التكاليف  |a الأرباح المالية  |a الشركات الدوائية  |a مصر 
692 |b Marketing Costs  |b Research and Development  |b Profitability  |b Pharmaceutical Companies 
700 |9 512054  |a Abouzeid, Walid Aboubakr  |e Co-Author 
773 |4 الاقتصاد  |6 Economics  |c 009  |e Scientific Journal for Accounting Researches  |l 002  |m مج1, ع2  |o 2083  |s المجلة العلمية للدراسات المحاسبية  |v 001  |x 2636-3739 
856 |u 2083-001-002-009.pdf 
930 |d y  |p y  |q n 
995 |a EcoLink 
999 |c 1098795  |d 1098795